Alison Berner

Has grant

NIHR Academic Clinical Lecturer

Queen Mary University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Alison Berner is an NIHR Academic Clinical Lecturer at Queen Mary University of London, UK. Her research focuses on the implications of genomics in colorectal cancer, healthcare improvements for transgender individuals, and methodologies related to cancer incidence in gender diverse populations. Her recent publications reflect her commitment to advancing understanding in transgender health issues and cancer risk assessment.

Recent Grants

Grant: Close

Harnessing the use of molecular signatures in research and clinical settings

Open Date: 2017-09-01

Close Date: 2018-08-01

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (7)

Yann Joly

CANADA

View details

Duncan Shrewsbury

University of Sussex

UNITED KINGDOM

View details

Catherine L. Saunders

University of Cambridge

UNITED KINGDOM

View details

Kate Nambiar

Cardiff and Vale University Health Board

UNITED KINGDOM

View details

Chloe Orkin

UNITED KINGDOM

View details

Cristina Espinosa da Silva

University of California, San Francisco

UNITED STATES

View details

Ian Charest

Professeur adjoint

Université de Montréal

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alison Berner

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

The Evolving Role of Genomics in Colorectal Cancer

Improving Health Care for Transgender People

Incidence of cervical intraepithelial neoplasia and cervical cancer in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study

Methodological considerations in the use of a large database to estimate incidence of prostate cancer in transgender women in the US

Methodology Concerns Regarding Claims Data Studies in Transgender Health

Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England

The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals

Demographic characteristics, long-term health conditions and healthcare experiences of 6333 trans and non-binary adults in England: nationally representative evidence from the 2021 GP Patient Survey

Analysis of Mortality Among Transgender and Gender Diverse Adults in England

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research

Researcher perspectives on ethics considerations in epigenetics: an international survey

Understanding the role of sex hormones in cancer for the transgender community.

Improving understanding of cancer in the gender diverse population

An evaluation of self-perceived knowledge, attitudes and behaviours of UK oncologists about LGBTQ+ patients with cancer

Collaborators (7)

Yann Joly

Duncan Shrewsbury

Catherine L. Saunders

Kate Nambiar

Chloe Orkin

Cristina Espinosa da Silva

Ian Charest

Make your next move.